Virtu Financial’s Cocrystal Pharma COCP Stock Holding History

Virtu Financial’s Portfolio COCP Stock Details COCP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13K	Buy	+13,080	New	+$13.5K	﹤0.01%	1439
2022 Q4	–	Sell	-4,001	Closed	-$14K	–	1694
2022 Q3	$14K	Buy	+4,001	New	+$18.7K	﹤0.01%	1469
2022 Q2	–	Sell	-1,186	Closed	-$8K	–	1645
2022 Q1	$8K	Buy	+1,186	New	+$7.89K	﹤0.01%	1376
2021 Q4	–	Sell	-1,561	Closed	-$20K	–	1776
2021 Q3	$20K	Sell	1,561 -8,158	-84%	-$108K	﹤0.01%	1381
2021 Q2	$146K	Buy	9,719 +3,275	+51%	+$49.8K	0.01%	1101
2021 Q1	$107K	Buy	6,444 +3,578	+125%	+$72.7K	0.01%	1299
2020 Q4	$47K	Sell	2,866 -4,774	-62%	-$66.3K	0.01%	1240
2020 Q3	$85K	Buy	+7,640	New	+$139K	0.01%	738
2019 Q4	$14K	Buy	+2,362	New	+$23.6K	﹤0.01%	1352

Other funds holding COCP

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T3 Companies New York $76.8M AUM

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Virtu Financial's COCP Position: Q1 2026 in Review

Virtu Financial opened a new position in Cocrystal Pharma (COCP) in Q1 2026: 13,080 shares worth $13K. The stake represents ﹤0.01% of the portfolio and ranks #1439 among its holdings. This is a return to the name: Virtu Financial previously reported a position in COCP as recently as Q3 2022.

Virtu Financial first reported a position in COCP in Q4 2019 and has held it in 9 quarters since. The position peaked at $146K in Q2 2021. 26 funds tracked by Wall St. Rank hold COCP as of Q1 2026.

Virtu Financial held 13,080 shares of Cocrystal Pharma worth $13K as of Q1 2026.
Cocrystal Pharma was a new Virtu Financial position in Q1 2026.
Cocrystal Pharma made up ﹤0.01% of Virtu Financial's portfolio in Q1 2026, its #1439 holding.
Virtu Financial first reported a position in Cocrystal Pharma in Q4 2019 and has held it in 9 quarters since.
Virtu Financial's Cocrystal Pharma position peaked at $146K in Q2 2021.
26 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.